Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 165 articles:
HTML format
Text format



Single Articles


    October 2018
  1. TSIAMBAS E, Riziotis C, Mastronikolis NS, Peschos D, et al
    Comparative p16(IKN4A) Expression in Laryngeal Carcinoma and Cervical Cancer Precursors: A Real-time Grid-based Immunocytochemistry Analysis.
    Anticancer Res. 2018;38:5805-5810.
    PubMed     Text format     Abstract available


  2. WOESTEMEIER A, Ghadban T, Riethdorf S, Harms-Effenberger K, et al
    Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
    Anticancer Res. 2018;38:5665-5669.
    PubMed     Text format     Abstract available


  3. PARK R, Williamson S, Kasi A, Saeed A, et al
    Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
    Anticancer Res. 2018;38:5569-5580.
    PubMed     Text format     Abstract available


  4. YIN F, Piao J, Liu X, Lai J, et al
    Foamy Histiocyte-like Esophageal Adenocarcinoma: Unusual Morphology and Diagnostic Pitfalls.
    Anticancer Res. 2018;38:5999-6002.
    PubMed     Text format     Abstract available


  5. ATHAUDA A, Watkins D, Mohammed K, Chau I, et al
    Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.
    Anticancer Res. 2018;38:5943-5949.
    PubMed     Text format     Abstract available


  6. VARRA V, Woody NM, Reddy C, Joshi NP, et al
    Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
    Anticancer Res. 2018;38:5825-5830.
    PubMed     Text format     Abstract available


  7. KANG SM, Kim J, Kang SH, Oh SY, et al
    Up-regulation of Bone Morphogenetic Protein 7 by 2-Hydroxycinnamaldehyde Attenuates HNSCC Cell Invasion.
    Anticancer Res. 2018;38:5747-5757.
    PubMed     Text format     Abstract available


  8. KIM JY, Park Y, Lee BM, Kim HS, et al
    P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Anticancer Res. 2018;38:5685-5692.
    PubMed     Text format     Abstract available


  9. VIRGILIO E, Ceci D, Cavallini M
    Surgical Endoscopic Vacuum-assisted Closure Therapy (EVAC) in Treating Anastomotic Leakages After Major Resective Surgery of Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:5581-5587.
    PubMed     Text format     Abstract available


    September 2018
  10. BETTE M, Nowak-Rossmann A, Mandic R
    The Auricular VX2 Carcinoma Is a Suitable Animal Model for Identifying Biomarkers for HNSCC Therapy Response.
    Anticancer Res. 2018;38:5067-5078.
    PubMed     Text format     Abstract available


  11. ARIGAMI T, Uchikado Y, Omoto I, Sasaki K, et al
    Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5447-5452.
    PubMed     Text format     Abstract available


  12. MERZ S, Timmesfeld N, Stuck BA, Wiegand S, et al
    Impact of Lymph Node Yield on Outcome of Patients with Head and Neck Cancer and pN0 Neck.
    Anticancer Res. 2018;38:5347-5350.
    PubMed     Text format     Abstract available


  13. HAYATA K, Ojima T, Nakamori M, Nakamura M, et al
    Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
    Anticancer Res. 2018;38:5267-5273.
    PubMed     Text format     Abstract available


  14. HEJLEH TA, Abushahin L, Keech J, Allen BG, et al
    Screening Patients with Esophageal Cancer to Determine Eligibility for Adjuvant Treatment Trials.
    Anticancer Res. 2018;38:5247-5251.
    PubMed     Text format     Abstract available


  15. JIANG P, Gu L, Zhou Y, Zhao Y, et al
    Synchronous Laryngeal Squamous Cell Carcinoma and Intrahepatic Cholangiocarcinoma Present in an Obese Male with Poor Prognosis.
    Anticancer Res. 2018;38:5547-5550.
    PubMed     Text format     Abstract available


  16. KUWAHARA T, Takahashi H, Sano D, Matsuoka M, et al
    Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5321-5330.
    PubMed     Text format     Abstract available


  17. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Text format     Abstract available


  18. FURUKAWA T, Hamai Y, Hihara J, Emi M, et al
    Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus.
    Anticancer Res. 2018;38:5239-5245.
    PubMed     Text format     Abstract available


  19. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:5211-5216.
    PubMed     Text format     Abstract available


  20. KIM H, Yang JM, Ahn SH, Jeong WJ, et al
    Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:5193-5200.
    PubMed     Text format     Abstract available


  21. KIM JY, Son JY, Lee BM, Kim HS, et al
    Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Anticancer Res. 2018;38:5149-5157.
    PubMed     Text format     Abstract available


    August 2018
  22. KONISHI T, Shiozaki A, Fujiwara H, Konishi H, et al
    Comparison of Feeding Jejunostomy via Gastric Tube Versus Jejunum After Esophageal Cancer Surgery.
    Anticancer Res. 2018;38:4941-4945.
    PubMed     Text format     Abstract available


  23. RADES D, Staackmann C, Janssen S
    Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer.
    Anticancer Res. 2018;38:4833-4837.
    PubMed     Text format     Abstract available


  24. BERSANI C, Haeggblom L, Ursu RG, Giusca SE, et al
    Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
    Anticancer Res. 2018;38:4683-4690.
    PubMed     Text format     Abstract available


  25. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Biomarkers of Oxidative Stress Associated with the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4661-4666.
    PubMed     Text format     Abstract available


  26. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 3-(N-Cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:4459-4467.
    PubMed     Text format     Abstract available


  27. NAGAI J, Shi H, Kubota Y, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of Pyrano[4,3-b]chromones.
    Anticancer Res. 2018;38:4449-4457.
    PubMed     Text format     Abstract available


    July 2018
  28. STROJAN P, Zakotnik B, Zumer B, Karner K, et al
    Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer.
    Anticancer Res. 2018;38:4213-4220.
    PubMed     Text format     Abstract available


  29. STAACKMANN C, Janssen S, Schild SE, Rades D, et al
    A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer.
    Anticancer Res. 2018;38:4199-4202.
    PubMed     Text format     Abstract available


  30. BAXA J, Ferda J, Ferdova E, Vojtisek R, et al
    Hybrid Imaging PET/CT with Application of (18)F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy.
    Anticancer Res. 2018;38:4153-4157.
    PubMed     Text format     Abstract available


  31. ALOTAIBY F, Song F, Boyce BJ, Cao D, et al
    Unusual Papillary Squamous Cell Carcinoma of the Tip of Tongue Presenting in a Patient Status Post Heart Transplant.
    Anticancer Res. 2018;38:4203-4206.
    PubMed     Text format     Abstract available


  32. SENGHORE T, Li YF, Sung FC, Tsai MH, et al
    Associations Between MTHFR Polymorphisms and the Risk of Potentially Malignant Oral Disorders.
    Anticancer Res. 2018;38:4021-4026.
    PubMed     Text format     Abstract available


  33. MOREIRA LF, Maino MM, Garbin HI, DA Natividade GR, et al
    CD117 Expression in Squamous Cell Carcinoma of the Oesophagus.
    Anticancer Res. 2018;38:3929-3933.
    PubMed     Text format     Abstract available


  34. SHI H, Nagai J, Sakatsume T, Bandow K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-(N-cyclicamino)chromone Derivatives.
    Anticancer Res. 2018;38:3897-3906.
    PubMed     Text format     Abstract available


  35. MERAM AT, Chen J, Patel S, Kim DD, et al
    Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.
    Anticancer Res. 2018;38:3843-3852.
    PubMed     Text format     Abstract available


    June 2018
  36. SIANO M, Jarisch N, Joerger M, Espeli V, et al
    Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer.
    Anticancer Res. 2018;38:3725-3729.
    PubMed     Text format     Abstract available


  37. RADES D, Bartscht T, Idel C, Schild SE, et al
    Hyperfractionated or Accelerated Hyperfractionated Re-irradiation with >/=42 Gy in Combination with Paclitaxel for Secondary/Recurrent Head-and-Neck Cancer.
    Anticancer Res. 2018;38:3653-3656.
    PubMed     Text format     Abstract available


  38. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Text format     Abstract available


  39. KIM JS, Choi DW, Kim CS, Yu SK, et al
    MicroRNA-203 Induces Apoptosis by Targeting Bmi-1 in YD-38 Oral Cancer Cells.
    Anticancer Res. 2018;38:3477-3485.
    PubMed     Text format     Abstract available


  40. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Text format     Abstract available


  41. JULOORI A, Koyfman SA, Geiger JL, Joshi NP, et al
    Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
    Anticancer Res. 2018;38:3543-3549.
    PubMed     Text format     Abstract available


  42. UESAWA Y, Sakagami H, Shi H, Hirose M, et al
    Quantitative Structure-Cytotoxicity Relationship of Furo[2,3-b]chromones.
    Anticancer Res. 2018;38:3283-3290.
    PubMed     Text format     Abstract available


  43. BOLM L, Kasmann L, Paysen A, Karapetis C, et al
    Multimodal Anti-tumor Approaches Combined with Immunotherapy to Overcome Tumor Resistance in Esophageal and Gastric Cancer.
    Anticancer Res. 2018;38:3231-3242.
    PubMed     Text format     Abstract available


  44. GANESH D, Sreenivasan P, Ohman J, Wallstrom M, et al
    Potentially Malignant Oral Disorders and Cancer Transformation.
    Anticancer Res. 2018;38:3223-3229.
    PubMed     Text format     Abstract available


    May 2018
  45. CHOI SH, Chang JS, Choi J, Park SH, et al
    Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Anticancer Res. 2018;38:3165-3173.
    PubMed     Text format     Abstract available


  46. RAMQVIST T, Ursu RG, Haeggblom L, Mirzaie L, et al
    Human Polyomaviruses Are Not Frequently Present in Cancer of the Salivary Glands.
    Anticancer Res. 2018;38:2871-2874.
    PubMed     Text format     Abstract available


  47. ASSAO A, Yoshino PM, Medeiros MCM, Carvalho AL, et al
    Moesin Involvement in Oral Carcinogenesis of the Lower Lip.
    Anticancer Res. 2018;38:2755-2760.
    PubMed     Text format     Abstract available


  48. KRAMER B, Kneissle M, Birk R, Rotter N, et al
    Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.
    Anticancer Res. 2018;38:2723-2731.
    PubMed     Text format     Abstract available


    April 2018
  49. FARINA E, Capuccini J, Macchia G, Caravatta L, et al
    Phase I-II Study of Short-course Accelerated Radiotherapy (SHARON) for Palliation in Head and Neck Cancer.
    Anticancer Res. 2018;38:2409-2414.
    PubMed     Text format     Abstract available


  50. SHIMAKAWA T, Naritaka Y, Asaka S, Miyazawa M, et al
    Innovations for Cervical Esophagogastrostomy in Thoracic Esophageal Cancer Operations.
    Anticancer Res. 2018;38:2323-2327.
    PubMed     Text format     Abstract available


  51. SHIH LC, Li CH, Sun KT, Chen LY, et al
    Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.
    Anticancer Res. 2018;38:2087-2092.
    PubMed     Text format     Abstract available


  52. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Text format     Abstract available


  53. MASTRONIKOLIS NS, Tsiambas E, Fotiades PP, Baliou E, et al
    Numerical Imbalances of Chromosome 7 in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:2339-2342.
    PubMed     Text format     Abstract available


  54. FRIEDRICH RE, Reul A
    Periapical Cemento-osseous Dysplasia Is Rarely Diagnosed on Orthopantomograms of Patients with Neurofibromatosis Type 1 and Is Not a Gender-specific Feature of the Disease.
    Anticancer Res. 2018;38:2277-2284.
    PubMed     Text format     Abstract available


  55. SEDER CW, Mahon B, Hennon M, Thomas M, et al
    Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma.
    Anticancer Res. 2018;38:2195-2200.
    PubMed     Text format     Abstract available


    March 2018
  56. BERNARDI D, Asti E, Aiolfi A, Bonitta G, et al
    Outcome of Trimodal Therapy in Elderly Patients with Esophageal Cancer: Prognostic Value of the Charlson Comorbidity Index.
    Anticancer Res. 2018;38:1815-1820.
    PubMed     Text format     Abstract available


  57. KUNIZAKI M, Hamasaki K, Wakata K, Tobinaga S, et al
    Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1807-1813.
    PubMed     Text format     Abstract available


  58. SUROV A, Leifels L, Meyer HJ, Winter K, et al
    Associations Between Histogram Analysis DCE MRI Parameters and Complex (18)F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1637-1642.
    PubMed     Text format     Abstract available


  59. RADES D, Seidl D, Janssen S, Hakim SG, et al
    A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers.
    Anticancer Res. 2018;38:1611-1613.
    PubMed     Text format     Abstract available


  60. GUO JC, Lin CC, Huang TC, Huang PM, et al
    Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:1569-1577.
    PubMed     Text format     Abstract available


  61. LEE CC, Lin ML, Meng M, Chen SS, et al
    Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
    Anticancer Res. 2018;38:1377-1389.
    PubMed     Text format     Abstract available


  62. GLAAS MF, Wiek C, Wolter LM, Roellecke K, et al
    Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2018;38:1317-1325.
    PubMed     Text format     Abstract available


  63. ZIVICOVA V, Gal P, Mifkova A, Novak S, et al
    Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1279-1290.
    PubMed     Text format     Abstract available


  64. SUEFUJI H, Koto M, Demizu Y, Saitoh JI, et al
    A Retrospective Multicenter Study of Carbon Ion Radiotherapy for Locally Advanced Olfactory Neuroblastomas.
    Anticancer Res. 2018;38:1665-1670.
    PubMed     Text format     Abstract available


  65. POST CM, Lin C, Adeberg S, Gupta M, et al
    National Practice Patterns for Clinical T1N0 Nasopharyngeal Cancer in the Elderly: A National Cancer Data Base Analysis.
    Anticancer Res. 2018;38:1651-1657.
    PubMed     Text format     Abstract available


  66. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Text format     Abstract available


  67. KAWASAKI G, Naruse T, Furukawa K, Umeda M, et al
    mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study.
    Anticancer Res. 2018;38:1623-1628.
    PubMed     Text format     Abstract available


  68. YUDA M, Nishikawa K, Takahashi K, Kurogochi T, et al
    A Strategy for Using Intraoperative Nerve Monitoring During Esophagectomy to Prevent Recurrent Laryngeal Nerve Palsy.
    Anticancer Res. 2018;38:1563-1567.
    PubMed     Text format     Abstract available


  69. SU W, Miles BA, Posner M, Som P, et al
    Surveillance Imaging in HPV-related Oropharyngeal Cancer.
    Anticancer Res. 2018;38:1525-1529.
    PubMed     Text format     Abstract available


  70. KATO K, Shimasaki M, Kato T, Segami N, et al
    Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1361-1368.
    PubMed     Text format     Abstract available


  71. SAIDAK Z, Morisse MC, Chatelain D, Sauzay C, et al
    Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours.
    Anticancer Res. 2018;38:1343-1352.
    PubMed     Text format     Abstract available


  72. HATA M
    Radiation Therapy for Angiosarcoma of the Scalp: Total Scalp Irradiation and Local Irradiation.
    Anticancer Res. 2018;38:1247-1253.
    PubMed     Text format     Abstract available


    February 2018
  73. KONISHI H, Fujiwara H, Shiozaki A, Shoda K, et al
    Effects of Neoadjuvant 5-Fluorouracil and Cisplatin Therapy in Patients with Clinical Stage II/III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:1017-1023.
    PubMed     Text format     Abstract available


  74. SAKAI M, Sohda M, Miyazaki T, Yoshida T, et al
    Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy.
    Anticancer Res. 2018;38:933-938.
    PubMed     Text format     Abstract available


  75. NAKAJIMA M, Muroi H, Kikuchi M, Takahashi M, et al
    Adverse Prognostic Factors of Advanced Esophageal Cancer in Patients Undergoing Induction Therapy with Docetaxel, Cisplatin and 5-Fluorouracil.
    Anticancer Res. 2018;38:911-918.
    PubMed     Text format     Abstract available


  76. YANAGI M, Sasaki K, Uchikado Y, Omoto I, et al
    Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer.
    Anticancer Res. 2018;38:893-900.
    PubMed     Text format     Abstract available


  77. ERNST BP, Mikstas C, Stover T, Stauber R, et al
    Association of eIF4E and SPARC Expression with Lymphangiogenesis and Lymph Node Metastasis in Hypopharyngeal Cancer.
    Anticancer Res. 2018;38:699-706.
    PubMed     Text format     Abstract available


  78. TATEBE H, Doi H, Ishikawa K, Kawakami H, et al
    Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
    Anticancer Res. 2018;38:979-986.
    PubMed     Text format     Abstract available


  79. YOSHIDA S, Shimo T, Murase Y, Takabatake K, et al
    The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:955-962.
    PubMed     Text format     Abstract available


  80. SAKAGAMI H, Okudaira N, Uesawa Y, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Azolylchromones.
    Anticancer Res. 2018;38:763-770.
    PubMed     Text format     Abstract available


  81. UESAWA Y, Sakagami H, Okudaira N, Toda K, et al
    Quantitative Structure-Cytotoxicity Relationship of Cinnamic Acid Phenetyl Esters.
    Anticancer Res. 2018;38:817-823.
    PubMed     Text format     Abstract available


  82. CIERPIKOWSKI P, Lis-Nawara A, Gajdzis P, Bar J, et al
    PDGFRalpha/HER2 and PDGFRalpha/p53 Co-expression in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2018;38:795-802.
    PubMed     Text format     Abstract available


    January 2018
  83. EGUCHI K, Suzuki M, Ida S, Mori K, et al
    Association Between Laryngopharyngeal Reflux and Radiation-induced Mucositis in Head and Neck Cancer.
    Anticancer Res. 2018;38:477-480.
    PubMed     Text format     Abstract available


  84. RADES D, Bartscht T, Idel C, Hakim SG, et al
    Re-irradiation with 36 Gy (1.5 Gy Twice Daily) Plus Paclitaxel for Advanced Recurrent and Previously Irradiated SCCHN is Feasible.
    Anticancer Res. 2018;38:519-523.
    PubMed     Text format     Abstract available


  85. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


  86. DOMINGUEZ C, Rosa M, George TB, Pimiento J, et al
    Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
    Anticancer Res. 2018;38:367-372.
    PubMed     Text format     Abstract available


  87. ISHIBASHI K, Ishii K, Sugiyama G, Sumida T, et al
    Deregulation of Nicotinamide N-Methyltransferase and Gap Junction Protein Alpha-1 Causes Metastasis in Adenoid Cystic Carcinoma.
    Anticancer Res. 2018;38:187-197.
    PubMed     Text format     Abstract available


    December 2017
  88. ANDREOU A, Pesthy S, Struecker B, Dadras M, et al
    Incidence and Risk Factors of Symptomatic Hiatal Hernia Following Resection for Gastric and Esophageal Cancer.
    Anticancer Res. 2017;37:7031-7036.
    PubMed     Text format     Abstract available


  89. SENTO S, Kitamura N, Yamamoto T, Nakashiro K, et al
    Palonosetron Prevents Highly Emetogenic Chemotherapy-induced Nausea and Vomiting in Oral Cancer Patients.
    Anticancer Res. 2017;37:6977-6981.
    PubMed     Text format     Abstract available


  90. FARINA E, Ferioli M, Castellucci P, Farina A, et al
    (18)F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art.
    Anticancer Res. 2017;37:6523-6532.
    PubMed     Text format     Abstract available


  91. RADES D, Bajrovic A, Bartscht T
    Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands.
    Anticancer Res. 2017;37:7011-7015.
    PubMed     Text format     Abstract available


  92. KOTSUMA T, Yamazaki H, Masui K, Yoshida K, et al
    Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Anticancer Res. 2017;37:6887-6892.
    PubMed     Text format     Abstract available


  93. FUJII H, Iihara H, Kajikawa N, Kobayashi R, et al
    Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.
    Anticancer Res. 2017;37:6831-6837.
    PubMed     Text format     Abstract available


  94. KURODA H, Kurio N, Shimo T, Matsumoto K, et al
    Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.
    Anticancer Res. 2017;37:6731-6737.
    PubMed     Text format     Abstract available


    November 2017
  95. CHO JH, Joo YH, Shin EY, Park EJ, et al
    Anticancer Effects of Colchicine on Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:6269-6280.
    PubMed     Text format     Abstract available


  96. LIU KC, Lin YJ, Hsiao YT, Lin ML, et al
    Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.
    Anticancer Res. 2017;37:6107-6118.
    PubMed     Text format     Abstract available


  97. CHOU PY, Lee MM, Lin SY, Sheu MJ, et al
    Pipoxolan Exhibits Antitumor Activity Toward Oral Squamous Cell Carcinoma Through Reactive Oxygen Species-mediated Apoptosis.
    Anticancer Res. 2017;37:6391-6400.
    PubMed     Text format     Abstract available


  98. UESAWA Y, Sakagami H, Ikezoe N, Takao K, et al
    Quantitative Structure-Cytotoxicity Relationship of Aurones.
    Anticancer Res. 2017;37:6169-6176.
    PubMed     Text format     Abstract available


  99. SAKAGAMI H, Uesawa Y, Masuda Y, Tomomura M, et al
    Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
    Anticancer Res. 2017;37:6161-6168.
    PubMed     Text format     Abstract available


  100. OBATA K, Shimo T, Okui T, Matsumoto K, et al
    Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:6119-6123.
    PubMed     Text format     Abstract available


  101. SUGITA Y, Takao K, Uesawa Y, Sakagami H, et al
    Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity.
    Anticancer Res. 2017;37:5919-5924.
    PubMed     Text format     Abstract available


    October 2017
  102. MOTOYAMA S, Sato Y, Sasaki T, Wakita A, et al
    Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Anticancer Res. 2017;37:5837-5843.
    PubMed     Text format     Abstract available


  103. HAMAI Y, Hihara J, Emi M, Furukawa T, et al
    Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5639-5646.
    PubMed     Text format     Abstract available


  104. GOPPEL J, Mockelmann N, Munscher A, Sauter G, et al
    Expression of Epithelial-Mesenchymal Transition Regulating Transcription Factors in Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:5435-5440.
    PubMed     Text format     Abstract available


  105. LIM HS, Kim CS, Kim JS, Yu SK, et al
    Suppression of Oral Carcinoma Oncogenic Activity by microRNA-203 via Down-regulation of SEMA6A.
    Anticancer Res. 2017;37:5425-5433.
    PubMed     Text format     Abstract available


  106. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Text format     Abstract available


  107. JANG JY, Pak KJ, Yi KI, Ki YK, et al
    Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer.
    Anticancer Res. 2017;37:5899-5905.
    PubMed     Text format     Abstract available


  108. FUJIMOTO Y, Nakashima Y, Sasaki S, Jogo T, et al
    Chemoradiotherapy for Solitary Skeletal Muscle Metastasis from Oesophageal Cancer: Case Report and Brief Literature Review.
    Anticancer Res. 2017;37:5687-5691.
    PubMed     Text format     Abstract available


  109. MASTRONIKOLIS NS, Tsiambas E, Papadas TA, Karameris A, et al
    Deregulation of PTEN Expression in Laryngeal Squamous Cell Carcinoma Based on Tissue Microarray Digital Analysis.
    Anticancer Res. 2017;37:5521-5524.
    PubMed     Text format     Abstract available


  110. PISANI LP, Estadella D, Ribeiro DA
    The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis.
    Anticancer Res. 2017;37:5389-5394.
    PubMed     Text format     Abstract available


  111. ANGELIERI F, Yujra VQ, Oshima CTF, Ribeiro DA, et al
    Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review.
    Anticancer Res. 2017;37:5383-5388.
    PubMed     Text format     Abstract available


  112. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Text format     Abstract available


    September 2017
  113. KUDOU M, Shiozaki A, Fujiwara H, Konishi H, et al
    Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer.
    Anticancer Res. 2017;37:5301-5307.
    PubMed     Text format     Abstract available


  114. SOHDA M, Kumakura Y, Saito H, Kuriyama K, et al
    Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival.
    Anticancer Res. 2017;37:5045-5051.
    PubMed     Text format     Abstract available


  115. KUMABE A, Zenda S, Motegi A, Onozawa M, et al
    Long-term Clinical Results of Concurrent Chemoradiotherapy for Patients with Cervical Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5039-5044.
    PubMed     Text format     Abstract available


  116. FRANZEN AM, Coordes A, Franzen CK, Guenzel T, et al
    Are Multiple Tumors of the Parotid Gland Uncommon or Underestimated?
    Anticancer Res. 2017;37:5263-5267.
    PubMed     Text format     Abstract available


  117. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Text format     Abstract available


  118. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Text format     Abstract available


  119. GUTSCHENRITTER T, Machiorlatti M, Vesely S, Ahmad B, et al
    Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.
    Anticancer Res. 2017;37:5019-5025.
    PubMed     Text format     Abstract available


  120. OKAMOTO JY, Miyazaki A, Kobayashi JI, Miyamoto S, et al
    Induction and Analysis of Cytotoxic T-Lymphocytes that Recognize Autologous Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4889-4897.
    PubMed     Text format     Abstract available


    August 2017
  121. WANG Y, Li D, Liu R, Jia C, et al
    Application of Ultrasound-guided Core Needle Biopsy in the Diagnosis of T3 or T4 Stage Laryngeal and Hypopharyngeal Cancer.
    Anticancer Res. 2017;37:4563-4567.
    PubMed     Text format     Abstract available


  122. LV Y, Jia C, Jiang A, Zhang H, et al
    Analysis of Association Between MGMT and p53 Gene Single Nucleotide Polymorphisms and Laryngeal Cancer.
    Anticancer Res. 2017;37:4399-4403.
    PubMed     Text format     Abstract available


  123. MOTOYAMA S, Sato Y, Maruyama K, Usami S, et al
    Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger Predictor of Survival in cStage IIB-IV Esophageal Cancer.
    Anticancer Res. 2017;37:4189-4194.
    PubMed     Text format     Abstract available


  124. HONJO H, Toh Y, Sohda M, Suzuki S, et al
    Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:4147-4155.
    PubMed     Text format     Abstract available


  125. PARK Y, Son JY, Lee BM, Kim HS, et al
    Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Anticancer Res. 2017;37:4139-4146.
    PubMed     Text format     Abstract available


  126. KLATKA J, Grywalska E, Hymos A, Guz M, et al
    Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer.
    Anticancer Res. 2017;37:4059-4066.
    PubMed     Text format     Abstract available


  127. WANG Y, Xu G, Wang J, Li XH, et al
    Relationship of Th17/Treg Cells and Radiation Pneumonia in Locally Advanced Esophageal Carcinoma.
    Anticancer Res. 2017;37:4643-4647.
    PubMed     Text format     Abstract available


  128. ZHANG W, Yin G, Dai J, Sun YU, et al
    Chemoprevention by Quercetin of Oral Squamous Cell Carcinoma by Suppression of the NF-kappaB Signaling Pathway in DMBA-treated Hamsters.
    Anticancer Res. 2017;37:4041-4049.
    PubMed     Text format     Abstract available


  129. REITER M, Harreus U
    Total Glossectomy Without Laryngectomy for Advanced Squamous Cell Cancer of the Tongue: Functional and Oncological Results.
    Anticancer Res. 2017;37:4233-4237.
    PubMed     Text format     Abstract available


    July 2017
  130. KITAGAWA H, Namikawa T, Hanazaki K
    Neck Dissection and Thoracoscopic Esophagectomy in Esophageal Cancer with Aberrant Subclavian Artery.
    Anticancer Res. 2017;37:3787-3790.
    PubMed     Text format     Abstract available


  131. HONMA Y, Hokamura N, Nagashima K, Sudo K, et al
    Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent.
    Anticancer Res. 2017;37:3741-3749.
    PubMed     Text format     Abstract available


  132. USLU U, Schuler G, Breuninger H
    Factors Influencing Disease Progression in Patients with Head and Neck Melanoma.
    Anticancer Res. 2017;37:3811-3816.
    PubMed     Text format     Abstract available


  133. FENG X, Matsuo K, Zhang T, Hu Y, et al
    MicroRNA Profiling and Target Genes Related to Metastasis of Salivary Adenoid Cystic Carcinoma.
    Anticancer Res. 2017;37:3473-3481.
    PubMed     Text format     Abstract available


    June 2017
  134. KAWAI T, Kochi M, Fujii M, Song K, et al
    Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:3301-3306.
    PubMed     Text format     Abstract available


  135. KALFERT D, Ludvikova M, Topolcan O, Celakovsky P, et al
    Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:3281-3286.
    PubMed     Text format     Abstract available


  136. UCHIYAMA Y, Kreiborg S, Murakami S, Tsujimoto T, et al
    Changes in the Submandibular Gland in Patients with Head and Neck Cancer After Radiation Therapy: A Preliminary Study.
    Anticancer Res. 2017;37:3239-3242.
    PubMed     Text format     Abstract available


  137. TARVAINEN L, Suojanen J, Kyyronen P, Lindqvist C, et al
    Occupational Risk for Oral Cancer in Nordic Countries.
    Anticancer Res. 2017;37:3221-3228.
    PubMed     Text format     Abstract available


  138. SUZUKI G, Yamazaki H, Aibe N, Masui K, et al
    Palliative Radiotherapy in the Local Management of Stage IVB Esophageal Cancer: Factors Affecting Swallowing and Survival.
    Anticancer Res. 2017;37:3085-3092.
    PubMed     Text format     Abstract available


  139. MIYATA H, Sugimura K, Motoori M, Fujiwara Y, et al
    Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2017;37:3053-3059.
    PubMed     Text format     Abstract available


  140. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Text format     Abstract available


  141. JANG S, Patel PN, Kimple RJ, McCulloch TM, et al
    Clinical Outcomes and Prognostic Factors of Adenoid Cystic Carcinoma of the Head and Neck.
    Anticancer Res. 2017;37:3045-3052.
    PubMed     Text format     Abstract available


  142. KRAMER B, Hock C, Schultz JD, Lammert A, et al
    Impact of Small Molecules on beta-Catenin and E-Cadherin Expression in HPV16-positive and -negative Squamous Cell Carcinomas.
    Anticancer Res. 2017;37:2845-2852.
    PubMed     Text format     Abstract available


    May 2017
  143. RADES D, Maderer A, Panzner A, Hunold P, et al
    Phase I Study of Definitive Radio-chemotherapy with Cisplatin, 5-Fluorouracil and Cetuximab for Unresectable Locally Advanced Esophageal Cancer.
    Anticancer Res. 2017;37:2703-2708.
    PubMed     Text format     Abstract available


  144. ZIVICOVA V, Broz P, Fik Z, Mifkova A, et al
    Genome-wide Expression Profiling (with Focus on the Galectin Network) in Tumor, Transition Zone and Normal Tissue of Head and Neck Cancer: Marked Differences Between Individual Patients and the Site of Specimen Origin.
    Anticancer Res. 2017;37:2275-2288.
    PubMed     Text format     Abstract available


  145. HAGEMANN J, Jacobi C, Hahn M, Schmid V, et al
    Spheroid-based 3D Cell Cultures Enable Personalized Therapy Testing and Drug Discovery in Head and Neck Cancer.
    Anticancer Res. 2017;37:2201-2210.
    PubMed     Text format     Abstract available


  146. CIESIELSKA U, Zatonski T, Nowinska K, Ratajczak-Wielgomas K, et al
    Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Anticancer Res. 2017;37:2407-2415.
    PubMed     Text format     Abstract available


    April 2017
  147. VEGH D, Banyai D, Hermann P, Nemeth Z, et al
    Type-2 Diabetes Mellitus and Oral Tumors in Hungary: A Long-term Comparative Epidemiological Study.
    Anticancer Res. 2017;37:1853-1857.
    PubMed     Text format     Abstract available


  148. DAVE E, Su W, Gupta V, Miles B, et al
    Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
    Anticancer Res. 2017;37:1847-1851.
    PubMed     Text format     Abstract available


  149. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


  150. P NS, Kang DY, Kim BJ, Joung YH, et al
    Methylsulfonylmethane Induces G1 Arrest and Mitochondrial Apoptosis in YD-38 Gingival Cancer Cells.
    Anticancer Res. 2017;37:1637-1646.
    PubMed     Text format     Abstract available


  151. SHIMIZU H, Shiozaki A, Fujiwara H, Konishi H, et al
    Short- and Long-term Progress of Recurrent Laryngeal Nerve Paralysis After Subtotal Esophagectomy.
    Anticancer Res. 2017;37:2019-2023.
    PubMed     Text format     Abstract available


  152. YUNOKI T, Tabuchi Y, Hayashi A
    Expression of Anti-apoptotic Protein BAG3 in Human Sebaceous Gland Carcinoma of the Eyelid.
    Anticancer Res. 2017;37:1931-1934.
    PubMed     Text format     Abstract available


  153. FANG CY, Liew PL, Chen CL, Lin YH, et al
    High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1891-1899.
    PubMed     Text format     Abstract available


  154. FUJIMURA T, Takahashi K, Kambayashi Y, Furudate S, et al
    Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal Artery.
    Anticancer Res. 2017;37:1885-1889.
    PubMed     Text format     Abstract available


    March 2017
  155. WAKITA A, Motoyama S, Nanjo H, Sato Y, et al
    PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic Esophageal Cancer Treated Without Adjuvant Chemotherapy.
    Anticancer Res. 2017;37:1433-1441.
    PubMed     Text format     Abstract available


  156. TORII C, Hida Y, Shindoh M, Akiyama K, et al
    Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1219-1225.
    PubMed     Text format     Abstract available


  157. NAKASHIMA S, Shiozaki A, Ichikawa D, Hikami S, et al
    Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1161-1167.
    PubMed     Text format     Abstract available


  158. TSENG HH, Tseng YK, You JJ, Kang BH, et al
    Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Anticancer Res. 2017;37:1059-1066.
    PubMed     Text format     Abstract available


  159. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


  160. KOGASHIWA Y, Yasuda M, Sakurai H, Nakahira M, et al
    PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1417-1424.
    PubMed     Text format     Abstract available


  161. THEOCHARIS S, Kotta-Loizou I, Giaginis C, Alexandrou P, et al
    Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1313-1319.
    PubMed     Text format     Abstract available


  162. SAKAGAMI H, Masuda Y, Tomomura M, Yokose S, et al
    Quantitative Structure-Cytotoxicity Relationship of Chalcones.
    Anticancer Res. 2017;37:1091-1098.
    PubMed     Text format     Abstract available


  163. TAKEDA D, Hasegawa T, Ueha T, Iwata E, et al
    Induced Pluripotent-stem-cell Related Genes Contribute to De-differentiation in Oral Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1075-1082.
    PubMed     Text format     Abstract available


  164. HARA K, Miyazaki T, Yokobori T, Yoshida T, et al
    Significance and Function of MicroRNA-7 in Oesophageal Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:1043-1048.
    PubMed     Text format     Abstract available


  165. SAKAGAMI H, Okudaira N, Masuda Y, Amano O, et al
    Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.
    Anticancer Res. 2017;37:1023-1029.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: